News Focus
News Focus
icon url

jq1234

02/21/14 6:06 PM

#174633 RE: kris_kade #174632

Because previously analysts gave ABBV/ENTA very tiny market share, 10 or 15%, to revise revenue up, all they need is to increase market share even without increase of overall HCV market.